CG Oncology Stock Forecast

Stock Price Forecast

According to 11 professional analysts, the 12-month price target for CG Oncology stock ranges from a low of $47 to a high of $90. The average analyst price target of $67.64 forecasts a 56.21% increase in the stock price over the next year.

Price Target: $67.64 (+56.21%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$47	$67.64	$75	$90
Change	+8.55%	+56.21%	+73.21%	+107.85%

Analyst Ratings

The average analyst rating for CG Oncology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	6	6	6	7	8	7
Buy	4	5	6	6	6	5
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	11	12	13	14	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Gregory Renza Truist Securities	Truist Securities	Strong Buy Initiates $62	Strong Buy	Initiates	$62	+43.19%	Nov 24, 2025
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $53 → $61	Buy	Maintains	$53 → $61	+40.88%	Nov 17, 2025
Brad Canino Guggenheim	Guggenheim	Strong Buy Initiates $90	Strong Buy	Initiates	$90	+107.85%	Oct 8, 2025
Brian Cheng JP Morgan	JP Morgan	Buy Maintains $41 → $47	Buy	Maintains	$41 → $47	+8.55%	Sep 26, 2025
Jeffrey Hung Morgan Stanley	Morgan Stanley	Buy Maintains $56 → $79	Buy	Maintains	$56 → $79	+82.45%	Sep 17, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.89M

from 1.14M

66.11%

from 1.14M

Revenue Next Year

57.13M

from 1.89M

2,919.34%

from 1.89M

EPS This Year

-2.20

from -1.41

EPS Next Year

-2.77

from -2.20

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	10.36M	191.00K	204.00K	1.14M	1.89M	57.13M	127.84M
Revenue Growth	-	-98.16%	6.81%	458.33%	66.11%	2,919.34%	123.79%
EPS	-5.04	-11.71	-15.65	-1.41	-2.20	-2.77	-2.46
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	16	16	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	2.4M	268.6M
Avg	1.9M	57.1M
Low	1.7M	n/a

Revenue Growth

Revenue Growth	2025	2026
High	112.0%	14,094.0%
Avg	66.1%	2,919.3%
Low	46.3%	-

EPS Forecast

EPS	2025	2026
High	-2.01	-1.77
Avg	-2.20	-2.77
Low	-2.21	-3.26

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.